Research Topics
Genomes and Genes | Yair LotanSummaryAffiliation: University of Texas Southwestern Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Primary prevention of nephrolithiasis is cost-effective for a national healthcare systemYair Lotan
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
BJU Int 110:E1060-7. 2012..Future studies will need to assess the feasibility and effectiveness of such an approach in a population...
Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectivenessY Lotan
Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas Electronic address
J Urol 189:935-9. 2013..We evaluated the economic impact of preventing recurrent stones using a strategy of increased water intake and determined the impact of compliance on cost-effectiveness for the French health care system...
Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECTYair Lotan
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
J Urol 187:2005-10. 2012..Epidemiological and biological evidence suggests a preventive effect of selenium and vitamin E on bladder cancer. We assessed the effect of selenium and/or vitamin E on bladder cancer development...
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomyYair Lotan
Department of Urology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 9110, USA
J Clin Oncol 23:6533-9. 2005..We hypothesized that bladder cancer patients with associated lymphovascular invasion (LVI) are at increased risk of occult metastases...
Economics and cost of care of stone diseaseYair Lotan
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
Adv Chronic Kidney Dis 16:5-10. 2009..These efforts include improving dietary recommendations, identifying barriers to evaluations and treatment of recurrent stone formers, improving patient compliance with recommendations, and development of new medications...
The effect of the approach to radical prostatectomy on the profitability of hospitals and surgeonsYair Lotan
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA
BJU Int 105:1531-5. 2010....
Considerations on implementing diagnostic markers into clinical decision making in bladder cancerYair Lotan
Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
Urol Oncol 28:441-8. 2010..Moreover, we attempt to outline criteria for the clinical utility of new bladder cancer diagnostic markers...
Cost-effectiveness of bladder cancer screeningYair Lotan
Assistant Professor of Urology, Department of Urology, The University of Texas, Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9110, USA
Expert Rev Pharmacoecon Outcomes Res 7:627-32. 2007..Studies need to be performed to evaluate the feasibility and cost-effectiveness of screening high-risk populations such as smokers...
Economics of stone managementYair Lotan
Department of Urology, The University of Texas Southwestern Medical Center, J8 112, 5323 Harry Hines Blvd, Dallas, TX 75390, USA
Urol Clin North Am 34:443-53. 2007..For single and recurrent stone formers, medical prophylactic strategies involving drug therapy are more costly than conservative therapy involving dietary measures alone. However, drug strategies yield fewer stone recurrences...
Role of biomarkers to predict outcomes and response to therapyYair Lotan
Department of Urology, The University of Texas, Southwestern Medical Center, Dallas, TX 75390 9110, USA
Urol Oncol 28:97-101. 2010..Furthermore, markers may guide targeted therapy. Prospective trials are needed to validate the clinical benefit of assessing expression patterns of molecular biomarkers...
Despite PSA screening and the control by radical prostatectomy, patients treatment fails and have a PSA recurrenceYair Lotan
Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX 75309-9110, USA
Eur Urol 52:453-4. 2007
Economics of robotics in urologyYair Lotan
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
Curr Opin Urol 20:92-7. 2010..This review will discuss general concepts of health economics and apply them to the application of robotics to urologic procedures...
Screening for bladder cancer: a perspectiveYair Lotan
Department of Urology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9110, USA
World J Urol 26:13-8. 2008..In this article, we will review the pros and cons of bladder cancer screening with a focus on cost-effectiveness and who should be screened...
Key concerns about the current state of bladder cancer: a position paper from the Bladder Cancer Think Tank, the Bladder Cancer Advocacy Network, and the Society of Urologic OncologyYair Lotan
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
Cancer 115:4096-103. 2009....
Bladder cancer screening in a high risk asymptomatic population using a point of care urine based protein tumor markerYair Lotan
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
J Urol 182:52-7; discussion 58. 2009..We evaluated whether screening high risk asymptomatic individuals with a bladder tumor marker can lead to earlier detection and resultant down staging of bladder cancer...
Are urologists fairly reimbursed for complex procedures: failure of 22 modifier?Yair Lotan
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
Urology 72:494-7. 2008..The 22 modifier was designed to provide surgeons with additional reimbursement for performing complex procedures. We evaluated whether urologists at a tertiary referral center are reimbursed when using the 22 modifier...
International comparison of cost effectiveness of medical management strategies for nephrolithiasisYair Lotan
Department of Urology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA
Urol Res 33:223-30. 2005..The differential resource allocation to different components of a healthcare system (i.e. subsidized medication versus surgical treatment) in different countries determines the cost effectiveness of various treatment strategies...
Cost-effectiveness of primary prevention strategies for nephrolithiasisYair Lotan
Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
J Urol 186:550-5. 2011..Stone disease is a highly prevalent condition associated with substantial cost and morbidity. We evaluated the cost-effectiveness of a primary prevention strategy...
The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomyYair Lotan
Departments of Urology and Pathology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9110, USA
J Urol 171:2209-14. 2004..We examined if the percent of positive biopsies is associated with features of biologically aggressive prostate cancer, biochemical progression and development of distant metastases in patients undergoing radical prostatectomy (RP)...
The new economics of radical prostatectomy: cost comparison of open, laparoscopic and robot assisted techniquesYair Lotan
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
J Urol 172:1431-5. 2004..We evaluated the costs components of laparoscopic (LRP) and robot assisted prostatectomy (RAP), and compared their costs to those of open radical retropubic prostatectomy (RRP)...
Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladderYair Lotan
Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9110, USA
J Urol 179:2164-9. 2008..We prospectively evaluated the clinical usefulness of fluorescence in situ hybridization assay for treating patients with atypical cytology who are at risk for bladder cancer...
The value of your time: evaluation of effects of changes in medicare reimbursement rates on the practice of urologyYair Lotan
Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
J Urol 172:1958-62. 2004..We studied the effect of these changes on hourly reimbursement rates for various services provided by urologists...
Prevention of bladder cancer recurrence by retinoic acid-ketoconazole: a promising strategy?Yair Lotan
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
Cancer Biol Ther 7:101-2. 2008
Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detectionYair Lotan
Department of Urology, University of Texas, Southwestern Medical Center, Dallas, TX 75390, USA
BJU Int 101:1362-7. 2008..Newton, MA, USA) for the detection of bladder cancer, as this is a point-of-care assay that measures NMPs in voided urine...
A cost comparison of nephron-sparing surgical techniques for renal tumourYair Lotan
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
BJU Int 95:1039-42. 2005..To compare costs associated with open partial nephrectomy (OPN), laparoscopic PN (LPN) and percutaneous radiofrequency ablation (PRF) in consecutive patients undergoing nephron-sparing surgery...
Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomesYair Lotan
Department of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 9110, USA
J Clin Oncol 23:1911-20. 2005..To assess the estimated effect of finasteride prevention of prostate cancer on overall survival...
Is robotic surgery cost-effective: noYair Lotan
Department of Urology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
Curr Opin Urol 22:66-9. 2012..This review will evaluate the cost-effectiveness of using robotics in urologic surgery...
Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomyShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
J Urol 182:78-84; discussion 84. 2009..We tested whether the combination of immunohistochemical markers could risk stratify cases of pT1 urothelial carcinoma of the bladder at radical cystectomy...
Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patientsAmit Gupta
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
Eur Urol 55:1124-33. 2009..This axis is involved in cell proliferation, angiogenesis, extracellular matrix degradation, invasion, and metastases...
Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinomaEugene K Cha
Department of Urology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY 10065, USA
Eur Urol 61:818-25. 2012..Novel prognostic factors for patients after radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) have recently been described...
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research ConsortiumShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
J Urol 176:2414-22; discussion 2422. 2006..We present the characteristics and outcomes of a large, contemporary, consecutive series of patients treated with radical cystectomy and pelvic lymphadenectomy for transitional cell carcinoma of the bladder...
Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation studyShahrokh F Shariat
Departments of Urology and Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
Clin Cancer Res 15:7012-9. 2009..Specimens showing at least 10% reactivity were considered altered. Predictive accuracy was quantified using the concordance index and 200-bootstrap resamples were used to reduce overfit bias...
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomyShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
Eur Urol 51:152-60. 2007..The aim of this study was to assess whether presence of concomitant CIS has a detrimental effect on cancer control after radical cystectomy...
Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancerShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 10065, USA
J Urol 183:68-75. 2010..We also assessed whether the combination of molecular markers is superior to any individual biomarker...
Association of angiogenesis related markers with bladder cancer outcomes and other molecular markersShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
J Urol 183:1744-50. 2010....
Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohortsBahaa S Malaeb
Department of Urology, University of Minnesota, Minneapolis, MN 55455, USA
Urol Oncol 25:291-7. 2007..To evaluate the feasibility of radical retropubic prostatectomy (RRP) as an option for treating men older than 70 years with organ confined prostate cancer and to compare biochemical progression-free survival with younger cohorts...
Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomyJose A Karam
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
Lancet Oncol 8:128-36. 2007....
p53 expression in patients with advanced urothelial cancer of the urinary bladderShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA
BJU Int 105:489-95. 2010..To test whether assessing p53 expression could improve the ability to predict disease recurrence and disease-specific survival in a multi-institutional cohort of patients with advanced urothelial carcinoma of the urinary bladder (UCB)...
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomyGuru Sonpavde
Michael E DeBakey Veterans Affairs Medical Center, Houston, TX, USA
BJU Int 108:687-92. 2011..To stratify risk of pathological (p) T2N0 urothelial carcinoma of the bladder after radical cystectomy (RC) based on pathological factors to facilitate the development of adjuvant therapy trials for high-risk patients...
Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancerVitaly Margulis
Department of Urologic Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
J Natl Cancer Inst 101:114-9. 2009....
Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancerGuru Sonpavde
Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
J Urol 185:456-61. 2011..We identified an association between disease-free survival at 2 to 3 years and 5-year overall survival...
Caveolin-1 overexpression is associated with aggressive prostate cancer recurrenceJose A Karam
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
Prostate 67:614-22. 2007....
Primary adenocarcinoma of the urinary bladder: value of cell cycle biomarkersPayal Kapur
Dept of Pathology, University of Texas Southwestern, 5323 Harry Hines Blvd, Dallas, TX 75390 9110, USA
Am J Clin Pathol 135:822-30. 2011..04). Stage, lymph node involvement, combined alterations of p27 and Ki-67, and combined alterations of all 5 biomarkers were associated with increased probability of disease recurrence and cancer-specific mortality (P < .05)...
Nomograms provide improved accuracy for predicting survival after radical cystectomyShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, and The Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, MD, USA
Clin Cancer Res 12:6663-76. 2006....
The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinomaCenk Gurbuz
University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
J Endourol 25:775-9. 2011..Our data support the continued role of ureteroscopic ablation of UTUC in appropriately selected patients...
Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma CollaborationRamy F Youssef
UT Southwestern Medical Center, Dallas, TX, USA
BJU Int 108:1286-91. 2011..To describe a multicentre experience with preoperative platinum-based chemotherapy before radical nephroureterectomy (RNU) in patients with upper tract urothelial carcinoma (UTUC) with loco-regional nodal metastases...
Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinomaHarun Fajkovic
Department of Urology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York 10065, USA
J Urol 187:845-51. 2012..We assessed the prognostic value of extranodal extension and other lymph node parameters in a large multicenter cohort of patients with lymph node metastasis after radical nephroureterectomy...
Laparoscopic interstitial laser coagulation of renal tissue with and without hilar occlusion in the porcine modelMatthew T Gettman
Department of Pathology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9110, USA
J Endourol 16:565-70. 2002..However, histologic evidence of viable cells within the treatment zone mandates refinement of the technique in the animal model before further application in humans. Hilar occlusion does not appear to enhance tissue ablation...
Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumoursJoshua M Stern
Department of Urology, University of Texas, Southwestern Medical Center, Dallas, TX 75390 9110, USA
BJU Int 100:287-90. 2007....
Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined diseaseVitaly Margulis
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9110, USA
Clin Cancer Res 12:7369-73. 2006..041). CONCLUSIONS: Ki-67 overexpression is associated with features of aggressive bladder TCC and adds independent prognostic information to standard pathologic features for prediction of clinical outcome after radical cystectomy...
The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomyThomas F Chromecki
Department of Urology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY 10065, USA
Eur Urol 61:245-53. 2012..The prognostic impact of multifocal upper-tract urothelial carcinoma (UTUC) is poorly understood...
The influence of body mass index on the cost of radical prostatectomy for prostate cancerChristian Bolenz
Departments of Urology, University of Texas Southwestern Medical Center at Dallas, TX, USA
BJU Int 106:1188-93. 2010..to evaluate the impact of obesity on the costs of robotic-assisted (RALP), laparoscopic (LRP) and open retropubic radical prostatectomy (RRP)...
Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomyShahrokh F Shariat
University of Texas Southwestern, Dallas, TX, USA
BJU Int 105:1672-7. 2010..To assess the impact of patient age on outcomes after radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC)...
Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tractVitaly Margulis
Department of Urology, UT Southwestern Medical Center, Dallas, Texas 75390 9110, USA
J Urol 184:453-8. 2010..We created a prognostic tool for the accurate preoperative prediction of nonorgan confined upper tract urothelial carcinoma...
Predictive value of plasma hepatocyte growth factor/scatter factor levels in patients with clinically localized prostate cancerAmit Gupta
Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
Clin Cancer Res 14:7385-90. 2008..We assessed whether preoperative plasma levels of HGF can enhance the accuracy of standard models for predicting pathologic features and clinical outcomes...
Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomyShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
Cancer 112:315-25. 2008....
Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladderJose A Karam
Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9110, USA
Urology 70:482-6. 2007..Our objectives were to evaluate the association of survivin expression with the presence of urothelial cell carcinoma of the bladder and clinical outcomes in patients with non-muscle-invasive urothelial cell carcinoma of the bladder...
The cost of prostate cancer chemoprevention: a decision analysis modelRobert S Svatek
The University of Texas Southwestern Medical Center at Dallas, TX 75390-9110, USA
Cancer Epidemiol Biomarkers Prev 15:1485-9. 2006..Targeting populations at higher risk for developing prostate cancer, however, allows for considerable flexibility in the medication cost to make prostate cancer chemoprevention a more attainable goal...
Prognostic value of syndecan-1 expression in patients treated with radical prostatectomyShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
BJU Int 101:232-7. 2008....
Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressivenessShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
Mod Pathol 20:445-59. 2007..In contrast to the use of single biological markers, evaluation of their combined status may improve prognostic models and help identify patients who might benefit from adjuvant therapies and in decision-making...
Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomySeyed M Khoddami
Department of Urology, The University of Texas South-western Medical Center, Dallas, USA
BJU Int 94:42-6. 2004..Recognising the distinction in GS 7 between predominant 4 vs 3 scores after radical prostatectomy should improve the ability of clinicians to counsel patients. The GS 4 pattern deserves further molecular study...
Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladderJose A Karam
Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
Clin Cancer Res 13:4400-6. 2007..Little is known about the expression of this gene in urothelial carcinoma of the bladder (UCB). We profiled DOC-2/DAB2 expression in mouse and human normal and neoplastic urothelia...
Preoperative plasma HER2 and epidermal growth factor receptor for staging and prognostication in patients with clinically localized prostate cancerShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9110, USA
Clin Cancer Res 13:5377-84. 2007..We tested the hypothesis that plasma levels of HER2 and/or EGFR are associated with prostate cancer stage and prognosis in patients with clinically localized disease...
The influence of clinical and pathological stage discrepancy on cancer specific survival in patients treated for renal cell carcinomaRobert S Svatek
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9110, USA
J Urol 176:1321-5; discussion 125. 2006..Implications of such clinical and pathological stage discrepancy should be considered when counseling patients and determining therapeutic approaches...
Laparoscopic partial nephrectomy using holmium laser in a porcine modelYair Lotan
Department of Urology, University of Texas Southwestern Medical Center at Dallas, 75390-9110, USA
JSLS 8:51-5. 2004..CONCLUSIONS: The Holmium:YAG laser provides an efficacious modality for transecting the kidney in a porcine model. Clinical trials are necessary to determine its role in laparoscopic partial nephrectomy in humans...
Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomyShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
Eur Urol 51:137-49; discussion 149-51. 2007..We compared clinical and pathologic staging in a large, contemporary, consecutive series of patients who were treated with radical cystectomy and pelvic lymphadenectomy, and determined the effect of stage discrepancy on outcomes...
Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancerShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
J Urol 176:919-26; discussion 926. 2006..We assessed variability in the diagnostic performance of NMP22 for detecting recurrence and progression in patients with Ta, T1, and/or CIS transitional cell carcinoma of the bladder in a large international cohort...
Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladderVitaly Margulis
Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9110, USA
J Urol 177:1163-8. 2007....
Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkersShahrokh F Shariat
Department of Urology, Weill Cornell Medical Center, New York, NY, USA
J Urol 187:457-62. 2012..We tested whether assessing the expression of cell cycle related proteins (p53, pRB, p21 and p27) could predict clinical outcomes after radical cystectomy in patients with organ confined urothelial carcinoma of the bladder...
Survivin expression is associated with bladder cancer presence, stage, progression, and mortalityShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center at Dallas, Texas 75390 9110, USA
Cancer 109:1106-13. 2007....
High-risk patients with hematuria are not evaluated according to guideline recommendationsKeren Elias
Department of Urology, University of Texas Southwestern Medical Center at Dallas, TX, USA
Cancer 116:2954-9. 2010..To determine whether high-risk patients with hematuria receive evaluation according to guideline recommendations...
General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term resultsAmit Gupta
Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
J Endourol 23:1099-105. 2009..We evaluated intermediate-term outcomes of patients undergoing percutaneous contrast-enhanced computed tomography (CT)-guided radiofrequency ablation (RFA) under general anesthesia (GA) at two high-volume centers...
Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancerChristian Bolenz
Department of Urology, University of Texas Southwestern Medical Center at Dallas, TX 75390 9110, USA
Eur Urol 57:453-8. 2010..Demand and utilization of minimally invasive approaches to radical prostatectomy have increased in recent years, but comparative studies on cost are lacking...
Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancerRobert S Svatek
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
Cancer 106:1701-7. 2006....
Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse modelLance Walsh
Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390-9110, USA
Eur Urol 50:795-800; discussion 800. 2006..These results are preliminary--but promising--and encourage further research into this application of ablative hypofractionated radiation for kidney cancer...
Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomyAmit Gupta
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
Urology 71:302-7. 2008..The aim of the present study was to assess the pathologic features and clinical outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma (UCBC) treated with radical cystectomy...
Laparoscopic versus open retroperitoneal lymph node dissection: a cost analysisKenneth Ogan
Clinical Center for Minimally Invasive Urologic Cancer Treatment, Dallas, Texas, USA
J Urol 168:1945-9; discussion 1949. 2002..Our model identifies several measures that can be applied at any institution to render laparoscopic retroperitoneal lymph node dissection economically superior to the open approach...
Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approachYair Lotan
Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA
J Urol 167:75-9. 2002..This protocol should be evaluated in a prospective randomized trial to determine whether the financial and emotional benefits outweigh any potential drawbacks...
Evaluation of costs and morbidity associated with laparoscopic radiofrequency ablation and laparoscopic partial nephrectomy for treating small renal tumoursKarim Bensalah
Department of Urology, University of Texas South western Medical Center at Dallas, Dallas, Texas 75390 9110, USA
BJU Int 101:467-71. 2008..To compare the costs and morbidity of laparoscopic radiofrequency ablation (LRFA) and laparoscopic partial nephrectomy (LPN) for treating small localized renal tumours...
Cost-effective treatment for ureteropelvic junction obstruction: a decision tree analysisMatthew T Gettman
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA
J Urol 169:228-32. 2003..However, cost is only 1 of a number of factors that are considered when deciding on an optimal course of treatment...
Survivin: a promising biomarker for detection and prognosis of bladder cancerVitaly Margulis
Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
World J Urol 26:59-65. 2008..These preliminary findings should now be confirmed in large prospective trials. Furthermore, simplified, quantitative and reproducible assays need to be developed and validated for the detection of Survivin and its different isoforms...
Contemporary laparoscopic and open radical retropubic prostatectomy: pathologic outcomes and Kattan postoperative nomograms are equivalentSangtae Park
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
Urology 69:118-22. 2007....
Cost comparison of hand assisted laparoscopic nephrectomy and open nephrectomy: analysis of individual parametersYair Lotan
Department of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
J Urol 170:752-5. 2003..In response to budgetary pressure at our large county hospital we reviewed the published experience and identified the cost components of HAL that could be targeted to decrease procedure cost...
Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysisRobert S Svatek
Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
Cancer 112:1058-65. 2008..8% (risk reduction) but questions remain regarding the cost-effectiveness of widespread utilization. The purpose of the current analysis was to evaluate the cost-effectiveness of chemoprevention utilizing a quality-of-life adjustment...
p53 predictive value for pT1-2 N0 disease at radical cystectomyShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center, Dallas, USA
J Urol 182:907-13. 2009..We determined whether p53 expression would improve the prediction of disease progression after radical cystectomy for pT1-2N0M0 UCB...
Cost utility of prostate cancer chemoprevention with dutasteride in men with an elevated prostate specific antigenRobert S Svatek
Department of Urology, The University of Texas San Antonio, TX, USA
Cancer Prev Res (Phila) 4:277-83. 2011..8%, but questions remain regarding the cost-effectiveness of widespread utilization. We evaluated the cost utility of chemoprevention using dutasteride in men at elevated risk for CaP...
Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasisShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center at Dallas, TX 75390 9110, USA
Hum Pathol 37:1568-76. 2006..Cyclin E1 expression stratifies patients with bladder transitional cell carcinoma into those with more "indolent" behavior and those with features of biologically and clinically aggressive disease...
Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasiaShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9110, USA
J Urol 174:2046-50. 2005..CONCLUSIONS: Survivin is over expressed in BPH and it correlates with BPH parameters. Increases in proliferation and inhibition of apoptosis have a role in BPH...
Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladderShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center, Dallas, 75390 9110, USA
Eur Urol 48:424-31. 2005....
Mesh kits for anterior vaginal prolapse are not cost effectiveSunshine Murray
Department of Urology, University of Texas Southwestern, 5323 Harry Hines Blvd, Dallas, TX 75390 9110, USA
Int Urogynecol J 22:447-52. 2011..To analyze the cost-effectiveness of traditional anterior colporrhaphy (AC), hand-cut mesh, and mesh kit anterior vaginal prolapse (AVP) repair...
Nomograms for bladder cancerShahrokh F Shariat
Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
Eur Urol 54:41-53. 2008..Physicians need tools to accurately estimate the risk of recurrence and cancer-specific mortality to recommend individualized therapy and to design appropriate clinical trials...
Survivin expression is associated with features of biologically aggressive prostate carcinomaShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 91120, USA
Cancer 100:751-7. 2004....
Should we screen for bladder cancer in a high-risk population?: A cost per life-year saved analysisYair Lotan
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
Cancer 107:982-90. 2006..The U.S. Food and Drug Administration recently approved screening high-risk patients for bladder cancer using urine-based markers. The cost and life-years saved associated with bladder cancer screening were evaluated...
Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladderShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 9110, USA
Urol Oncol 25:468-75. 2007..To determine the association of cyclin D1 and E1 expression with bladder cancer presence, clinical and molecular characteristics, and disease progression in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder...
Gastrointestinal hemorrhage as first manifestation of metastatic testicular tumorShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical School, Dallas, Texas 75390 9110, USA
Urology 66:1319. 2005..He underwent ileal enterectomy, radical orchiectomy, and several cycles of chemotherapy (cisplatin, etoposide, and bleomycin). He died within 41 days of diagnosis...
Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/mlShahrokh F Shariat
Department of Urology, The University of Texas Southwestern Medical Center at Dallas, TX 75390 9110, USA
Eur Urol 49:293-302. 2006..To evaluate the association of total prostate specific antigen (T-PSA) and percent free PSA (%F-PSA) with prostate cancer outcomes in patients treated with radical prostatectomy (RP)...
Open to debate. The motion: prevention of prostate cancer with a 5alpha-reductase inhibitor is feasibleClaus G Roehrborn
Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA
Eur Urol 49:396-400. 2006
Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinomaShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
J Urol 177:481-7; discussion 487. 2007..We determined whether the combined expression of p53, p21, p27 and pRB is associated with outcomes of patients with nonmuscle invasive bladder transitional cell carcinoma...
Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladderShahrokh F Shariat
Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
J Urol 173:1518-25. 2005..We developed and validated nomograms that accurately predict disease recurrence and progression in patients with Ta, T1, or CIS transitional cell carcinoma (TCC) of the bladder using a large international cohort...
Cost comparison for laparoscopic nephrectomy and open nephrectomy: analysis of individual parametersYair Lotan
Department of Urology, University of Texas Southwestern Medical Center at Dallas, 75390, USA
Urology 59:821-5. 2002..LN is cost effective compared with ON if short operating times and brief length of stays are achieved...
Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinomaGeorg C Hutterer
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
BJU Int 101:561-5. 2008..To assess the value of nuclear matrix protein-22 (NMP22), compared with urinary cytology, in predicting the recurrence of bladder cancer that is not transitional cell carcinoma (non-TCC)...
